Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-04-21

Clinical Trial Update: 68Ga-NOTA-BBN-RGD PET/CT in Prostate Cancer Patients [EARLY_Phase 1]

View source ↗

Summary

This entry reports an early Phase 1 clinical trial evaluating 68Ga-NOTA-BBN-RGD PET/CT imaging in patients with prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 68Ga-NOTA-BBN-RGD

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Prostate Cancer | EARLY_Phase 1 | Status: UNKNOWN